Induction of β-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1

被引:115
作者
Cozar-Castellano, I
Takane, KK
Bottino, R
Balamurugan, AN
Stewart, AF
机构
[1] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Pittsburgh, PA USA
[2] Childrens Hosp Pittsburgh, Rangos Res Ctr, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Dept Surg, Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA
关键词
D O I
10.2337/diabetes.53.1.149
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The major regulator of the gap-1/synthesis phase (G(1)/S) cell cycle checkpoint is the retinoblastoma protein (pRb), and this is regulated in part by the activities of cyclin-dependent kinase (cdk)-4 and the D cyclins. Surprisingly, given the potential importance of beta-cell replication for islet replacement therapy, pRb presence, phosphorylation status, and function have not been explored in beta-cells. Here, adenoviruses expressing cdk-4 and cyclin D, were used to explore rat and human pRb phosphorylation and beta-cell cycle control. pRb is present in rat and human islets, and overexpression of cyclin D-1/cdk-4 led to strikingly enhanced pRb phosphorylation in both species. Combined overexpression of both cdk-4 and cyclin D-1 caused a threefold increase in [H-3]thymidine incorporation. This increase in proliferation was confirmed independently using insulin and bromodeoxyuridine immunohistochemistry, where human beta-cell replication rates were increased 10-fold. Cdk-4 or cyclin D-1 overexpression did not adversely effect beta-cell differentiation or function. The key cell cycle regulatory protein, pRb, can be harnessed to advantage using cyclin D-1/cdk-4 for the induction of human and rodent beta-cell replication, enhancing replication without adversely affecting function or differentiation. This approach will allow detailed molecular study of the cellular mechanisms regulating the cell cycle in beta-cells, beta-cell lines, and stem cell-derived beta-cells.
引用
收藏
页码:149 / 159
页数:11
相关论文
共 31 条
[1]   Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks [J].
Adams, PD .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1471 (03) :M123-M133
[2]  
BECKER TC, 1994, METHOD CELL BIOL, V43, P161
[3]   Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound [J].
Bottino, R ;
Balamurugan, AN ;
Bertera, S ;
Pietropaolo, M ;
Trucco, M ;
Piganelli, JD .
DIABETES, 2002, 51 (08) :2561-2567
[4]   Overexpression of parathyroid hormone-related protein inhibits pancreatic β-cell death in vivo and in vitro [J].
Cebrian, A ;
García-Ocaña, A ;
Takane, KK ;
Sipula, D ;
Stewart, AF ;
Vasavada, RC .
DIABETES, 2002, 51 (10) :3003-3013
[5]   Cell cycle entry of hematopoietic stem and progenitor cells controlled by distinct cyclin-dependent kinase inhibitors [J].
Cheng, T ;
Scadden, DT .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (05) :460-465
[6]   Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors [J].
Chung, DC ;
Brown, SB ;
Graeme-Cook, F ;
Seto, M ;
Warshaw, AL ;
Jensen, RT ;
Arnold, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4373-4378
[7]   Glucagon-like peptides [J].
Drucker, DJ .
DIABETES, 1998, 47 (02) :159-169
[8]   BETA-CELL LINES DERIVED FROM TRANSGENIC MICE EXPRESSING A HYBRID INSULIN GENE ONCOGENE [J].
EFRAT, S ;
LINDE, S ;
KOFOD, H ;
SPECTOR, D ;
DELANNOY, M ;
GRANT, S ;
HANAHAN, D ;
BAEKKESKOV, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :9037-9041
[9]  
Efrat S, 1996, DIABETES REV, V4, P224
[10]   DYNAMICS OF BETA-CELL MASS IN THE GROWING RAT PANCREAS - ESTIMATION WITH A SIMPLE MATHEMATICAL-MODEL [J].
FINEGOOD, DT ;
SCAGLIA, L ;
BONNERWEIR, S .
DIABETES, 1995, 44 (03) :249-256